Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYBR CyberCare the new look of healthcare -- Ignore unavailable to you. Want to Upgrade?

To: Sir Auric Goldfinger who wrote (775)	4/1/2000 11:56:00 PM
From: sommovigo	Respond to of 3392

Auric - you are unqualified to make those judgements. You are a serial short-seller by admission, and therefore have an extreme conflict of interest when you tell anyone to sell anything, because by doing that... you help to manipulate the price, thus adding to your profits. Dangerous life, the one you lead...

To: Sir Auric Goldfinger who wrote (775)	4/2/2000 12:04:00 AM
From: glenairlie	Read Replies (1) \| Respond to of 3392

Auric, you must be a control freak. You just finished complaining about the lack of revenues, and I posted the truth. The company, under Mike Morell's leadership, has gone from making a loss to making a profit. In a year. In fact, EPS is 10 times better. and revenues have tripled. This company is growing fast, and transitioning from a brick and mortar business to an internet-based healthcare business at the same time. No easy task, but they seem to be doing quite well so far, as the balance sheet proves. I expect expenses from their EHC development will impact the bottom line this year, no question. I just don't see where the problem lies. I am investing my retirement money here also (although I am far from retirement), and I see the EHC division as a division that has huge potential for growth. Sure, they may not succeed, but then this investment is not Blue Chip. Fact is, the EHC provides patient cost-savings of 30%-50% for HMO's, and documented trials prove it. That is significant. Risk vs Reward is the name of the game here. Anyone who doesn't realise the risk of any new venture shouldn't be in this, or any internet type stock. Period. Bottom line, this is a company with huge potential, a turn-around story, and I hope Morrell continues to execute the business plan.